Used in pharmaceutical research as an intermediate for synthesizing biologically active compounds, particularly in the development of kinase inhibitors. The structure featuring pyridine, benzimidazole, and a piperidine ring supports binding to specific enzyme targets, showing potential in studies related to anti-inflammatory and anticancer agents. The carbamic acid tert-butyl ester group serves as a protecting group that can be removed in later synthesis steps to yield the active compound. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs targeting chronic diseases requiring high molecular specificity.